Genetic Screening/Testing
Genetic screening refers to the use of specific tests to determine which members of a population are at increased risk for an inherited condition. Genetic testing, in contrast, is the use of specific tests to characterize the genetic status of an individual who is suspected to be at increased risk for an inherited disease. These terms are frequently used interchangeably.
What's New at ASRM
- SART Fertility Experts - Preimplantation Testing for Monogenic Disease (PGT-M)
- ASRM Today: Genetic Counselor Awareness with Rachel Donnell and Jenna Miller
- ASRM Today: PGT with Dr. Richard Paulson
- January 2023 - Repro Reader
- Canadian Class Action Lawsuit for Fertility Fraud Against MD Settled for $13.375m
Resources
Publications
- Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion (2018)
- Disclosure of sex when incidentally revealed as part of preimplantation genetic testing (PGT): an Ethics Committee opinion (2018)
- Use of reproductive technology for sex selection for nonmedical reasons: an Ethics Committee opinion (2022)
- Clinical management of mosaic results from preimplantation genetic testing for aneuploidy (PGT-A) of blastocysts: a committee opinion (2020)
- The role of immunotherapy in in vitro fertilization: a guideline (2018)
- The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion (2018)
- Ethics Webinar: Transferring Abnormal Embryos After Preimplantation Genetic Testing
- Infertility Workup for the Women’s Health Specialist (2019)